ACT CAPITAL MANAGEMENT, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2022$4,064,000
+4.9%
58,300
-1.2%
5.61%
+3.5%
Q2 2022$3,874,000
-1.3%
59,0000.0%5.42%
+30.4%
Q1 2022$3,926,000
-4.9%
59,0000.0%4.15%
+39.3%
Q4 2021$4,127,000
+97.7%
59,000
+47.5%
2.98%
+175.7%
Q3 2021$2,088,000
+60.9%
40,000
+109.7%
1.08%
+62.2%
Q2 2021$1,298,00019,0750.67%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders